Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
BE5FkfSMn7e3rwJ3